Skip to content

In the News: The Risks and Rewards of Decentralized Clinical Trials

DCTs completely revise historical trial processes by executing trials through telemedicine and mobile or local health care providers. Although COVID increased the need for DCTs, 75% of the industry report very little use of decentralized and virtual trials. Read more from Dario Lirio, Senior Director, LifeSphere Clinical, over on PharmaLive.

Breakthrough 2022 JOIN US FOR BREAKTHROUGH 2022.         Learn more and register today